Form 4 for BIO BIO-RAD LABORATORIES, INC.
Accepted 2024-09-04 00:00:00 ET · period of report 2024-09-01 · accession 0001062993-24-016172 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-09-04 | 2024-09-01+ | BIO | COREY COLLEEN | EVP, Gbl Human Resources | F - Tax | $336.56 | -700 | 18.2K | -4% | -$235.6K |
| DM | 2024-09-04 | 2024-09-01+ | BIO | COREY COLLEEN | EVP, Gbl Human Resources | M - OptEx | $0.00 | +1,956 | 18.3K | +12% | $0 |
| DM | 2024-09-04 | 2024-09-01+ | BIO | COREY COLLEEN | EVP, Gbl Human Resources | M - OptEx | $0.00 | -1,956 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 124 | $337.32 | 17,767 | D | — | — | |
| 2 | Common | Bio-Rad A Common Stock | 2024-09-03 | F | D | 177 | $334.31 | 18,479 | D | — | — | |
| 3 | Common | Bio-Rad A Common Stock | 2024-09-03 | M | A | 495 | $0.00 | 18,656 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 4 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 500 | $0.00 | 17,723 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 5 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 179 | $337.32 | 17,544 | D | — | — | |
| 6 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 347 | $0.00 | 17,891 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 7 | Common | Bio-Rad A Common Stock | 2024-09-01 | M | A | 253 | $0.00 | 18,020 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 8 | Common | Bio-Rad A Common Stock | 2024-09-01 | F | D | 91 | $337.32 | 17,929 | D | — | — | |
| 9 | Common | Bio-Rad A Common Stock | 2024-09-02 | M | A | 361 | $0.00 | 18,290 | D | — | — | (F1) Shares of Class A common stock acquired on the vesting of restricted stock units. |
| 10 | Common | Bio-Rad A Common Stock | 2024-09-02 | F | D | 129 | $337.32 | 18,161 | D | — | — | |
| 11 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 347 | $0.00 | 694 | D | $0.00 · — to — | 347 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F4) On September 1, 2022, the reporting person was granted 1,388 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 12 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 500 | $0.00 | 1,503 | D | $0.00 · — to — | 500 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F3) On September 1, 2023, the reporting person was granted 2,003 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 13 | Derivative | Restricted Stock Units | 2024-09-03 | M | D | 495 | $0.00 | 0 | D | $0.00 · — to — | 495 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F7) On September 3, 2019, the reporting person was granted 2,475 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date. |
| 14 | Derivative | Restricted Stock Units | 2024-09-01 | M | D | 253 | $0.00 | 254 | D | $0.00 · — to — | 253 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F5) On September 1, 2021, the reporting person was granted 1,013 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |
| 15 | Derivative | Restricted Stock Units | 2024-09-02 | M | D | 361 | $0.00 | 0 | D | $0.00 · — to — | 361 Bio-Rad A Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock. (F6) On September 2, 2020, the reporting person was granted 1,444 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date. |